Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Committee for Contraception Research (ICCR) is a specialized clinical research division of the Population Council focused on the development of novel contraceptive technologies. Established in 1970, the ICCR brings together an international network of scientists to design, test, and bring to market long-acting reversible contraceptives (LARCs) and multipurpose prevention technologies. The committee has been instrumental in the development of landmark products such as the Norplant implant, the Mirena intrauterine system, and the Annovera vaginal ring. Its work spans the entire development spectrum from early-stage clinical trials to regulatory approval and post-marketing surveillance. By partnering with pharmaceutical companies and global health organizations, the ICCR aims to expand reproductive health options and improve access to family planning worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Committee for Contraception Research of the Population Council.